Literature DB >> 7756356

Molecular cloning of PEPT 2, a new member of the H+/peptide cotransporter family, from human kidney.

W Liu1, R Liang, S Ramamoorthy, Y J Fei, M E Ganapathy, M A Hediger, V Ganapathy, F H Leibach.   

Abstract

Mammalian kidney is known to express a transport system specific for small peptides and pharmacologically active aminocephalosporins. This system is energized by a transmembrane electrochemical H+ gradient. Recently, a H(+)-coupled peptide transporter has been cloned from rabbit and human intestine (Fei et al. (1994) Nature 368, 563-566; Liang et al., J. Biol. Chem., in press). Functional studies have established that the renal peptide transport system is similar but not identical to its intestinal counterpart. Therefore, in an attempt to isolate the renal H+/peptide cotransporter cDNA, we screened a human kidney cDNA library with a probe derived from the rabbit intestinal H+/peptide cotransporter cDNA. This has resulted in the isolation of a positive clone with a 2190 bp long open reading frame. The predicted protein consists of 729 amino acids. Hydropathy analysis of the amino acid sequence indicates the presence of twelve putative transmembrane domains. The primary structure of this protein exhibits 50% identity and 70% similarity to the human intestinal H+/peptide cotransporter. Functional expression of the kidney cDNA in HeLa cells results in the induction of a H(+)-coupled transport system specific for small peptides and aminocephalosporins. Reverse transcription-coupled polymerase chain reaction demonstrates that the cloned transporter is expressed in human kidney but not in human intestine. This transporter, henceforth called PEPT 2, represents a new member in the growing family of H(+)-coupled transport systems in the mammalian plasma membrane.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7756356     DOI: 10.1016/0005-2736(95)80036-f

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  49 in total

Review 1.  Intestinal peptide transport systems and oral drug availability.

Authors:  C Y Yang; A H Dantzig; C Pidgeon
Journal:  Pharm Res       Date:  1999-09       Impact factor: 4.200

2.  N-terminal halves of rat H+/peptide transporters are responsible for their substrate recognition.

Authors:  T Terada; H Saito; K Sawada; Y Hashimoto; K Inui
Journal:  Pharm Res       Date:  2000-01       Impact factor: 4.200

Review 3.  Targeted prodrug design to optimize drug delivery.

Authors:  H K Han; G L Amidon
Journal:  AAPS PharmSci       Date:  2000

4.  Genomic structure of proton-coupled oligopeptide transporter hPEPT1 and pH-sensing regulatory splice variant.

Authors:  A Urtti; S J Johns; W Sadée
Journal:  AAPS PharmSci       Date:  2001

5.  Cloning of a lymphatic peptide/histidine transporter.

Authors:  K Sakata; T Yamashita; M Maeda; Y Moriyama; S Shimada; M Tohyama
Journal:  Biochem J       Date:  2001-05-15       Impact factor: 3.857

6.  Switching between the two action modes of the dual-affinity nitrate transporter CHL1 by phosphorylation.

Authors:  Kun-Hsiang Liu; Yi-Fang Tsay
Journal:  EMBO J       Date:  2003-03-03       Impact factor: 11.598

7.  Preliminary investigation into the expression of proton-coupled oligopeptide transporters in neural retina and retinal pigment epithelium (RPE): lack of functional activity in RPE plasma membranes.

Authors:  Scott M Ocheltree; Richard F Keep; Hong Shen; Dongli Yang; Bret A Hughes; David E Smith
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

8.  Deorphaning a solute carrier 22 family member, SLC22A15, through functional genomic studies.

Authors:  Sook Wah Yee; Dina Buitrago; Adrian Stecula; Huy X Ngo; Huan-Chieh Chien; Ling Zou; Megan L Koleske; Kathleen M Giacomini
Journal:  FASEB J       Date:  2020-10-30       Impact factor: 5.191

9.  Muscle-Specific Insulin Receptor Overexpression Protects Mice From Diet-Induced Glucose Intolerance but Leads to Postreceptor Insulin Resistance.

Authors:  Guoxiao Wang; Yingying Yu; Weikang Cai; Thiago M Batista; Sujin Suk; Hye Lim Noh; Michael Hirshman; Pasquale Nigro; Mengyao Ella Li; Samir Softic; Laurie Goodyear; Jason K Kim; C Ronald Kahn
Journal:  Diabetes       Date:  2020-08-31       Impact factor: 9.461

10.  ERRgamma regulates cardiac, gastric, and renal potassium homeostasis.

Authors:  William A Alaynick; James M Way; Stephanie A Wilson; William G Benson; Liming Pei; Michael Downes; Ruth Yu; Johan W Jonker; Jason A Holt; Deepak K Rajpal; Hao Li; Joan Stuart; Ruth McPherson; Katja S Remlinger; Ching-Yi Chang; Donald P McDonnell; Ronald M Evans; Andrew N Billin
Journal:  Mol Endocrinol       Date:  2009-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.